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Background: Sacroiliac joint (SI) pain is an often-overlooked cause of low back pain due, in part, to lack of specific
findings on radiographs and symptoms mimicking other back-related disorders. We report our experience with
minimally invasive (MIS) SI joint arthrodesis using a series of triangular, titanium plasma spray (TPS) coated implants
in patients refractory to conservative care.
Methods: We report outcomes from 18 patients with 12 months of postoperative follow-up.
Demographics, complications, and clinical outcomes using visual analog scale (VAS) for pain, Oswestry Disability
Index (ODI) for back function and SF-12 for quality of life were collected preoperatively and at 3, 6 and 12 months
post-operatively.
Results: Mean age was 64 years and 67% of patients were female. There were no intraoperative complications and
one explant at three months for malposition.
All patient-reported outcomes showed both clinically and statistically significant improvement at 12 months
(p < 0.001 for each of the following): VAS improved by 6.6 points, ODI scores improved by −37.5 points. One year
SF-12 physical and mental component (PCS, MCS) scores approximated population normal scores for both physical
and mental functioning. Patient satisfaction with outcomes was high at 95%; 89% said would have the same
surgery again.
Conclusions: MIS SI joint fusion using a series of triangular porous TPS coated titanium implants is a safe and
effective procedure for patients with SI joint disorders who have failed conservative care.
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Sacroiliac (SI) joint pain is an often-overlooked cause of
low back pain. This may be due in part to the lack of
visible abnormalities on plain radiographs and the fact
that SI joint pain may mimic hip, lumbar radicular disor-
ders or pain of discogenic origin [1,2]. Patients with SI
joint problems may present with low back, groin, gluteal,
and/or radicular pain leading to the potential for in-
accurate diagnosis and treatment [3-5].
Historically, though the sacroiliac joint was a promin-
ent initial focus of attention in the early 1900s as a sig-
nificant generator of low back pain (LBP), as more
reliably diagnosed conditions such as herniated discs
and facet arthropathy became better understood, less* Correspondence: rcapobianco@si-bone.com
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distribution, and reproduction in any mediumfocus was placed on the SI joint [6]. A large study
conducted by Bernard and Kirkaldy-Willis found that
22.5% of patients diagnosed with nonspecific LBP actu-
ally had SI joint problems [1]. A more recent study
reported a prevalence rate between 15-30% of patients
presenting with low back pain [2]. Several studies inves-
tigating the affect of lumbar fusion on SI joint disorders
have shown an SI joint pain prevalence rate of up to
61% after lumbosacral fusion and significant radio-
graphic SI joint degeneration in up to 75% of post-
lumbar fusion patients at 5 years [7-9].
Open arthrodesis of the SI joint was commonly
performed in the early 1900s. However, open SI joint
fusion is less common now as it requires relatively large
incisions, significant bone harvesting, and lengthy hos-
pital stays; moreover, patients must avoid weight -
bearing for several months postoperatively [10-13].BioMed Central Ltd. This is an open access article distributed under the terms of
tp://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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with various devices. Recent reports of a minimally inva-
sive arthrodesis system have shown promising outcomes
[14,15]. The surgical procedure involves the placement
of three triangular implants across the SI joint (Figure 1).
Second site bone harvesting or graft is not required as
the porous titanium plasma spray (TPS) coating on the
implants results in biological fixation of the implant in
bone. Herein we report safety and effectiveness out-
comes of patients undergoing MIS SI joint fusion with a
series of triangular titanium, porous TPS coated im-
plants (iFuse Implant System, SI-BONE, Inc., San Jose,
CA) in a single surgeon’s private practice.
Methods
A medical chart review was undertaken to identify pa-
tients who underwent MIS SI joint fusion surgery at a
community based spine practice more than 12 months
ago. Patients were excluded if concomitant spine proce-
dures were performed and if no preoperative or follow
up outcomes were available. A total of 34 patients were
identified: 24 had one year follow up, 18 underwent uni-
lateral surgery and are included in our analysis. All pa-
tients were treated between September 2011 and AprilFigure 1 Triangular porous plasma coated implants (iFuse®
Implant System, SI-BONE Inc, San Jose, CA).2012. Data collected included patient demographics,
medical history, and complications of surgery. Clinical
outcomes were collected prospectively preoperatively
and at 6 weeks, 3 months, 6 and 12 months postopera-
tively. Institutional Review Board Approval (Community
Health Network) was obtained before beginning this
study.
Diagnosis
Using a combination of detailed history, clinical exam,
imaging and positive diagnostic injections, all patients
were diagnosed with either degenerative sacroiliitis or
sacroiliac joint disruption. A thorough physical and clin-
ical exam was performed in order to establish the pain
generator as accurately as possible in this complex popu-
lation. A positive result on 3 or more pain provocation
tests such as Gaenselen’s, flexion abduction external
rotation (FABER), compression, distraction and thigh
thrust, was used as criteria for further testing to confirm
the SI joint as the pain generator [16-19]. Diagnostic
imaging studies such as x-ray, CT and MRI, while not
sensitive in diagnosing disorders of the SI joint, are help-
ful in ruling out pathology in the lumbar spine and hip
[17]. When clinical, physical and imaging findings were
congruent, patients were sent for image-guided diagnos-
tic injections of the SI joint. A positive result was de-
fined as a 75% reduction in pain immediately following
injection of local anesthetic [20]. Conservative treatment
consisting of medication optimization, physical therapy
and SI joint injections was prescribed for a course of at
least 6 months before offering the patient surgery.
Technique overview
Minimally invasive SI joint fusion surgery was performed
in all cases by a single neurosurgeon in private practice.
This procedure involves fixation of the SI joint by pla-
cing a series (typically three) of triangular, titanium por-
ous TPS coated implants across the SI joint. No second
site bone harvesting is required due to the biological fix-
ation properties of the porous TPS coating. The patient
is placed in the prone position on a radiolucent table to
facilitate the use of intraoperative fluoroscopy. After
general endotracheal anesthesia is administered, the pa-
tient is prepped in the normal sterile fashion. A 3 cm
lateral incision is made into the buttock region and the
gluteal fascia is bluntly dissected to reach the outer table
of the ilium. A Steinmann pin is passed through the
ilium across the SI joint to the center of the sacrum
(lateral to the neural foramen). After a soft tissue pro-
tector is passed over the pin, a hand drill is used to cre-
ate a pathway and decorticate the bone. Finally, a
triangular broach is used to further decorticate the bone
and prepare the pathway to receive the first implant.
Using a pin guidance system, a total of three implants
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the sacral ala. The second implant is generally located
above or adjacent to the S1 foramen and the third be-
tween the S1 and S2 foramen (Figure 2). The incision is
then irrigated and the tissue layers are sequentially
closed. Patients begin physical therapy on day 1 postop
and are instructed to ambulate with the assistance of
a walker or crutch for the first 3 weeks. During the
3–6 week postoperative period, patients progress to full
weight bearing with a regimen of flexibility and strength-
ening exercises. After 6 weeks of gradual return to full
weight bearing, patients are back to unrestricted activity
and are encouraged to continue core stabilization exer-
cises as well as weight and cardiovascular training.
Clinical outcome assessments
Patient reported clinical outcomes were collected pro-
spectively prior to surgery to establish baseline values
and at 6 weeks, 3, 6 and 12 months post-operatively.
The following instruments were used: visual analog scale
(VAS) for pain, Oswestry Disability Index (ODI) (version
2.1) for back related function, and Short Form 12
(SF-12) for quality of life [21,22]. Satisfaction at
12 months was assessed by asking the patient 2 ques-
tions: “describe your satisfaction with this surgical out-
come” and “would you elect the have the same surgery
again?” Possible responses were “very, somewhat, or not
really” for question 1 and “definitely, likely, or definitely
not” for question 2.
Statistical analysis
Baseline demographic variables were summarized with
mean, standard deviation and frequency tables. Changes
in clinical outcomes variables (VAS, ODI, SF-12 PCSFigure 2 Postoperative radiograph demonstrating placement
of three implants across the SI joint.and MCS) were evaluated using a paired t-test. Analysis
of variance (ANOVA) was used to evaluate differences
in outcomes across subgroups. Subgroup variables ana-
lyzed were history of prior lumbar fusion, hypertension,
body mass index (BMI) by category, age (> or < 65 years)
and sex. BMI categories were defined using World
Health Organization (WHO) standards: <25 normal,
25–30 overweight, >30 obese. All analysis was performed
using SAS (version 9.0, Cary, NC).
Clinical improvement was defined using minimum
clinically important difference (MCID) and substantial
clinical benefit (SCB) values available in the literature.
Currently there are no reported MCID or SCB values for
SI joint fusion. We chose MCID thresholds for VAS pain
and ODI improvement reported in the Spine Patient
Outcomes Research Trial (SPORT): ≥2 points for VAS
pain and ≥12.8 for ODI [23]. MCID values for SF-12
PCS and MCS (8.8 and 9.3 points respectively) were ac-
quired from a study on lumbar spine surgery for adja-
cent segment disease, since the majority of the patients
in our cohort had a history of previous lumbar spine
fusion [24]. Substantial clinical benefit (SCB) values were
chosen using criteria by Glassman et al. for patients
undergoing lumbar spine arthrodesis [25]. SCB for ODI
is defined as an 18.8-point improvement or final score
of <31.3 points. SCB for SF-36 PCS is defined as 6.2-point
improvement or final score of ≥ 35.1 and SCB for pain is
2.5-point decrease or raw score of < 3.5.
ODI scores may be described in terms of degree of
disability. A score of 0-20% represents minimal dis-
ability, 21-40% moderate disability, 41-60% severe dis-
ability and 61-80% crippled (Table 1). Scores greater
than 81% were not seen in our population and are
described as “either bed bound or exaggerating their
symptoms.”Table 1 Score interpretation of the Oswestry disability
questionnaire [21] for low back pain
0% to 20%:
minimal disability:
The patient can cope with most living activities.
Usually no treatment is indicated apart from
advice on lifting sitting and exercise.
21%-40%:
moderate disability:
The patient experiences more pain and difficulty
with sitting, lifting and standing. Travel and
social life are more difficult and they may be
disabled from work. Personal care, sexual activity
and sleeping are not grossly affected and the




Pain remains the main problem in this group but
activities of daily living are affected. These
patients require a detailed investigation.
61%-80%: crippled: Back pain impinges on all aspects of the
patient’s life. Positive intervention is required.
81%-100%: These patients are either bed-bound or
exaggerating their symptoms.
Table 2 Patient demographics
N 18
Age 64 (range 39–81) (12.2 SD)
Sex 67% (12) F, 33% (6) M
Race 83% (15) Caucasian
17% (3) African American
BMI mean 31
Obese (>30) 61% (11)
Overweight (25–30) 28% (5)
Normal (<25) 11% (2)
Diabetes 21% (4)
Smoking status 2 current, 5 former
Hypertension 44% (8)




Side treated 11 L (61%), 7R (39%)
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Eighteen patients underwent unilateral MIS SI joint fu-
sion and had 1-year follow-up. No patient had a con-
comitant procedure. No intraoperative complications
were observed and blood loss was minimal (<50 cc) in
all cases. Mean age was 64 years (range 39–81) (Table 2).
Patients were primarily white (83%) and female (67%).
The large majority (89%) of patients in this cohort were
obese (BMI > 30) or overweight (BMI 25–30), and 44%
were hypertensive. Most patients (83%) had a history of
previous lumbar spine surgery that included: fusion at
one or more levels (73%), decompression (13%), and
discectomy (13%).
VAS pain scores improved clinically and statistically at
all postoperative time points (Table 3). Mean (SD) scores
improved from 8.9 (± 1.9) at baseline to 2.3 (2.1)
at 12 months with a mean change of −6.56 points
(p < .0001) for this time period (Table 4). A clinically sig-
nificant benefit, defined as ≥2 point change from base-
line, was observed in 90% of patients [23].
Back-related function measured on ODI improved
clinically and statistically. Improvement was observed as
early as the 6-week post-operative visit. Mean (SD) scoresTable 3 Clinical outcomes
Baseline 6wk
n Mean (SD) n Mean (SD) n
VAS 18 8.9 (1.9) 12 3.1 (1.6) 13
ODI 18 52.7 (18.8) 5 22.8 (19.8) 10
SF-12 PCS 18 32.3 (6.4) 6 38.1 (10.1) 9
SF-12 MCS 18 37.6 (10.2) 6 42.6 (13.1) 9decreased from 52.7 (18.8) at baseline to 13.2 (12.6)
at 12 months with a mean change of −37.5 points
(p < .0001). Baseline ODI scores categorized 61% of pa-
tients as “severely disabled,” 17% as “crippled,” and 2%
each as “moderately” and “minimally disabled.” At the
12 month visit, 89% of patients were classified into the
“minimal disability category” and the remaining 2 patients
scored into the “moderate disability” category [21]. Both of
these patients were considered as “severely disabled” at
baseline with multiple back pain complaints. Substantial
clinical benefit was achieved for 89% of patients.
Quality of life as measured on SF-12 using the aggre-
gate physical and mental component summary (PCS and
MCS) scores showed a clinically and statistically signifi-
cant improvement (p < 0.005, p < 0.001 respectively).
Mean PCS score rose from 32.3 (6.4) at baseline to 44.6
(10.5) at 12 months, representing an improvement in
physical health by 11.2 points. MCS scores improved
from 37.8 at baseline to 53.8 at 12 months, a mean im-
provement of 20.4 points. The SF-12 outcome measure
scale of 0–100 was designed such that a mean score of
50 with a standard deviation of 10 represents average
health status (United States population). The improve-
ment gained in our patient population is commensurate
with reported age category scores of the general US
population suggesting a return of health to near normal
levels. SCB and MCID were reached for 72% of patients
on SF-12 PCS. MCID (no SCB was available) for SF-12
MCS was reached in 78% of patients.
More than half of patients were “very satisfied” with
the surgical outcome only 1 patient (5.6%) was “not
really” satisfied (Table 5). When asked if they would have
the same surgery for the same result, 83% responded
“definitely,” 5.6% answered “likely,” and 11% indicated
“definitely not.”
Most (84%) patients had undergone previous lumbar
spine surgery. A subgroup analysis of improvement in
pain amongst those with and without a history of prior
lumbar spine fusion showed no difference in clinical
outcomes. Analysis of variance showed that other vari-
ables (history of hypertension, diabetes, smoking, age
and gender) had no affect on pain (VAS), function
(ODI), or quality of life (SF-12) improvements. Of inter-
est, 89% of patients had a BMI of greater than 25 indi-
cating they were overweight or obese. Although only a3mo 6mo 12mo
Mean (SD) n Mean (SD) n Mean (SD)
3.0 (2.5) 10 4.4 (3.2) 18 2.3 (2.1)
16.8 (16.4) 3 29.0 (12.7) 18 13.2 (12.6)
44.8 (10.2) 3 37.4 (1.9) 18 44.6 (10.5)
51.2 (11.3) 3 36.1 (2.1) 18 53.8 (9.5)
Table 4 12 month clinical outcomes
Baseline 12 mo Change p
VAS 8.9 (1.9) 2.3 (2.1) −6.56 <0.001
ODI 52.6 (18.8) 13.2 (12.6) −37.54 <0.001
SF-12 PCS 32.3 (6.4) 44.6 (10.5) 11.19 <0.005
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BMI range, subgroup analysis revealed no statistically
significant effect of BMI on outcomes.
Complications
There were no intraoperative complications. Postopera-
tively, one patient had fluid retention, three patients
experienced transient trochanteric bursitis treated with
medical management and one patient had transient toe
numbness of unclear relationship to SI joint fusion
surgery (Table 6). One operative site hematoma oc-
curred. In this same patient, a selective nerve root block
was performed at S1 to alleviate pain from a resulting
piriformis spasm. One patient experienced new radicular
pain at the 3 month visit. CT scan revealed the most
cephalad implant was seated just outside the anterior
cortex, resulting in an irritation of the L5 nerve root.
The implant was subsequently removed and the patient
had a complete resolution of radicular symptoms. The
resulting major complication rate as defined by Lebude
et al. [26] for this cohort was 5%.
Discussion
SI joint symptoms can present as pain in the SI joint,
low back, hip, groin, or buttock, and abnormalities are
rarely seen on plain radiographs alone [1,17]. To accur-
ately diagnose the SI joint as the pain generator in
patients with low back pain symptoms requires a com-
bination of detailed clinical history, physical exam ma-
neuvers that stress the SI joint, and marked pain relief
on diagnostic SI joint block [8,27].
Recent reports of MIS approaches to SI joint arthrod-
esis using hollow modular anchorage (HMA) screws
packed with demineralized bone matrix show relatively
good clinical results, but with room for improvement
[28-30]. However, recent reports suggest that this tech-
nique may not be appropriate for patients with a history
of instrumented spinal surgery. Mason et al. reportedTable 5 Satisfaction
Satisfaction with
surgical outcomes
Would you have the same
surgery for the same result?
Very 10 (55.6%) Definitely 15 (83.3%)
Somewhat 7 (38.9%) Likely 1 (5.6%)
Not really 1 (5.6%) Definitely not 2 (11.1%)significantly worse outcomes after SI joint fusion using
HMA screws in patients with a history of previous lum-
bar spine surgery [30]. In contrast, a recently published
report of outcomes after SI joint fusion using the tri-
angular implants reported herein (iFuse Implant System)
showed clinically and statistically significant improve-
ments in pain and function independent of a prior his-
tory of lumbar spine fusion [14]. Similarly, there was no
difference in outcomes in the current study between
patients with and without history of lumbar spinal
fusion. Recent case series reports using the same tech-
nique described herein report favorable results with
minimal complications and no suggestion of implant
loosening [14,15,31,32].
Advantages of a MIS approach over standard open fu-
sion include a small incision, minimal blood loss, bone
and ligament preservation, and a relatively short period
of immobilization. The triangular shape combined with
an interference fit of the titanium implant used in this
cohort was designed to minimize rotation and micro-
motion in order to avoid the issues of loosening, backing
out and implant protrusion that can be encountered
with traditional screws [33]. Due to both the porous na-
ture of the implant’s titanium plasma spray coating along
with the implant versus cage design, iliac crest bone
harvesting is not required.
Post-operative complications were minimal and the
most common complaint was transient trochanteric bur-
sitis. This is neither uncommon nor unexpected, and
can be a result of altered gait pattern due to low back or
hip pain, post-operative hip abductor weakness, in-
creased activity levels and other trauma in the region
[34]. One patient presented with pain in the L5 distribu-
tion 3 months after device placement. Impingement of
the distal end of the most cephalad implant on the L5
nerve root was revealed on CT scan. After the implant
was removed, the patient’s pain resolved completely.
This patient had an otherwise excellent outcome with a
12-month pain score of 1, an ODI score of 6, and nor-
mal SF-12 PCS and MCS scores. This finding under-
scores the importance of accurate device placement
during surgery.
Most patients in this cohort had a history of previous
lumbar spine surgery with the most common procedure
being instrumented fusion (75%). It is unclear whether
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segment disease (ASD) or de novo degeneration. Using
pre-determined thresholds (MCID or SCB where avail-
able) for clinically significant improvement, the success
rates observed in our study were high: 90% of patients
met this threshold for improvement in pain (VAS), 89%
for back related function (ODI), 72% for physical quality
of life (SF-12 PCS), 78% for mental quality of life (SF-12
MCS). Moreover, the presence of prior lumbar spine
fusion did not seem to affect improvement of pain and
functional scores.
Although the current study sample size is small, the
results are very encouraging. Favorable outcomes in this
cohort underscore the necessity to suspect the SI joint
as a pain generator in patients with low back pain
especially after lumbar spine surgery. Results for this
reported procedure in patients with instrumented fusion
are as favorable as in patients with no prior lumbar sur-
gical history. This procedure has the potential to signifi-
cantly benefit the elderly population, who are not
candidates for other conventional techniques due to
poor bone quality, delayed healing and reduced mobility.
Half of the patients in this cohort are 65 years or older
and a sub group analysis revealed no difference in out-
comes at one year for patients < or > 65 years. This seg-
ment of the population is not likely to respond well to
physical therapy alone in part because of the degenera-
tive nature of SI joint disease. The MIS procedure de-
scribed herein affords this segment of the population an
opportunity to regain mobility, alleviate SI joint and low
back pain caused by SI joint issues and experience an
improved quality of life.
Conclusion
Minimally invasive SI joint fusion using a series of tri-
angular porous TPS coated implants is effective in im-
proving pain, function and quality of life in patients with
disorders of the SI joint who have failed conservative
treatment. The complication rate was low.
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